Autologous haematopoietic stem cell transplantation in patients with multiple myeloma complicated by dialysis-dependent renal failureМ. В. Фирсова, Savchenko Vg, Л. П. Менделеева et al.|Terapevticheskii arkhiv|2020Cited by 7
Maintenance Therapy after Autologous Haematopoietic Stem Cell Transplantation (auto-HSCT) in Multiple Myeloma Patients with and without Minimal Residual Disease (MRD)Maxim Solovev, Savchenko Vg, Л. П. Менделеева et al.|Blood|2016Cited by 6
Prognostic value of 1q21 amplification in multiple myelomaTatiana Abramova, Savchenko Vg, Т. Н. Обухова et al.|Terapevticheskii arkhiv|2017Cited by 4
Multiple myeloma: Maintenance therapy after autologous hematopoietic stem cell transplantation, depending on minimal residual diseaseM. V. Solovyev, Savchenko Vg, Yulia Davydova et al.|Terapevticheskii arkhiv|2017Cited by 4
Autologous Haematopoietic Stem Cell Transplantation in Patients with Multiple Myeloma Complicated By Dialysis-Dependent Renal FailureMaiia V. Firsova, Savchenko Vg, Л. П. Менделеева et al.|Blood|2018Cited by 3